Breath-Hold Techniques
Breath-Hold Techniques
Breath-Hold Techniques
Original Article
a r t i c l e i n f o a b s t r a c t
Article history: The use of breath-hold techniques in radiotherapy, such as deep-inspiration breath hold, is increasing
Received 4 May 2023 although guidelines for clinical implementation are lacking. In these recommendations, we aim to pro-
Accepted 1 June 2023 vide an overview of available technical solutions and guidance for best practice in the implementation
Available online 8 June 2023
phase. We will discuss specific challenges in different tumour sites including factors such as staff training
and patient coaching, accuracy, and reproducibility. In addition, we aim to highlight the need for further
Keywords: research in specific patient groups. This report also reviews considerations for equipment, staff training
Motion management
and patient coaching, as well as image guidance for breath-hold treatments. Dedicated sections for speci-
Deep inspiration breath hold
Interfraction uncertainties
fic indications, namely breast cancer, thoracic and abdominal tumours are also included.
ESTRO ACROP guideline Ó 2023 The Authors. Published by Elsevier B.V. Radiotherapy and Oncology 185 (2023) 109734 This is an
open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Introduction BH techniques have been used for at least twenty years in RT.
However, the implementation has been slow, and the recent
In radiotherapy (RT), respiratory gating by using a breath-hold POP-ART survey has revealed large variations in usage amongst
(BH) technique has the potential to mitigate interfractional and RT centres and highlights that BH is still considerably under-used
intrafractional breathing-motion and/or to reduce the dose to [2]. As a result of this slow adoption, a considerable amount of
organs-at-risk (OARs), depending on the primary disease site. This pragmatic clinical knowledge is restricted to a few centres having
approach has been applied to different anatomical regions such as treated many patients. In this guideline, we have strived to com-
the thorax, breast and abdomen. bine recommendations both from published reports and from com-
The most common approach is the deep-inspiration breath- mon empirical experience (‘‘consensus of experts”) reflecting
hold (DIBH) technique: this technique requires the patients to current clinical practice. Though we recognise there is no ‘‘one-
inhale to a specified level and hold their breath during image size fits all” solution, we offer specific examples of the implemen-
acquisition and treatment delivery. Although less commonly tation of the selected technological solutions. We also discuss the
applied than DIBH, expiration BH can be advantageous for upper selection and coaching of patients, as well as specific issues relat-
abdominal tumours. ing to different patient groups (e.g. breast, lung, abdomen) for
Available strategies differ significantly with regard to adopted BH. The nomenclature used in this document is defined in Table 1
devices, additional equipment required, intrafractional monitoring and illustrated in Fig. 1.
and patient feedback systems [1]. This consensus guideline aims to
provide a broad overview of BH techniques with regard to available
solutions and their implementation, utilization, patient compli- Equipment
ance, benefits, and challenges, in order to facilitate the clinical
implementation (or expansion) of this procedure in daily practice. When implementing a BH technique in RT, a surrogate measure
for the position of the target is needed. The most commonly used
⇑ Corresponding author at: Division of Cancer Sciences, Faculty of Biology, surrogate measures can be roughly divided into surface-based or
Medicine and Health, University of Manchester, United Kingdom. spirometry-based equipment, often combined with visual feedback
E-mail address: [email protected] (M.C. Aznar). systems to the patient. The spectrum ranges from simple in-house
https://doi.org/10.1016/j.radonc.2023.109734
0167-8140/Ó 2023 The Authors. Published by Elsevier B.V.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Implementation of breath-hold techniques
Table 1
Glossary of types of breath-hold variations and their definition (BH = breath-hold). See also a visual representation in Fig. 1.
Nomenclature Definition
Interfraction BH Variation in breath-hold between different fractions (i.e. from one day to the next).Possible causes include variation in:
variation - breathing pattern (chest vs abdominal breathing);
- internal organ movement
- patient position (filling the lungs versus arching the spine).
- - drifts of organs due to relaxation/ gravity.
Intrafraction BH Variation in breath-hold within a single fraction (i.e. from beam-on to beam-stop).Possible causes include:
variation - drift due to relaxation or gravity
- patient exhaustion
- breathing pattern (chest vs abdominal breathing);
- internal organ movement
- patient position (filling the lungs versus arching the spine).
Includes two main components: BH-to-BH variation and intra-BH variation.
Intra-BH variation: Variation within a single breath-hold, e.g. a ‘‘deep” inspiration becoming less ‘‘deep” within seconds. The breath-hold
duration may be too long, or the patient may require direct feedback to maintain the breath-hold.
BH-to-BH variation: Variation from one breath-hold to the next within one treatment fraction. Can be caused by fatigue, shifts in patient
position as the treatment fraction is being delivered, or drifts of organs due to relaxation/gravity.
2
M.C. Aznar, P. carrasco de fez, S. Corradini et al. Radiotherapy and Oncology 185 (2023) 109734
has been reported that when patients try to achieve or maintain a breathing signal. Hence, regular target and organs at risk (OAR)
BH which is ‘‘too deep”, they may arch their back to compensate position verification with x-ray based images is recommended
for an insufficient BH level [14]. ‘‘Moderately deep” can be defined [25].
as roughly 70 to 85% of the maximum BH of each individual patient If the target is well correlated to bony structures (e.g., the breast
[12 15,16]. Note that in the published literature, the terms ‘‘deep” to the sternum), the position of the tumour and the BH level may
and ‘‘moderately deep” are often used interchangeably, but rarely be verified using 2D imaging (MV or kV), necessitating only a
reflect true differences in BH level. However, in the absence of few seconds of BH per image. However, it must be noted that 2D
quantitative measures, it can be useful to ask the patient to hold imaging can underestimate set-up uncertainties since not all axes
their breath without mentioning depth (‘‘imagine you’re going of deviations can be visualized [26]. A BH CBCT can be acquired
under water for 15 sec”) to achieve a natural BH. over several short consecutive BHs while pausing the image acqui-
Most patients are able to hold their breath for 25–30 seconds: sition manually to allow the patients to catch their breath, or in a
reports suggest that > 90% of breast cancer patients can achieve single BH with a fast CBCT image acquisition. Some modern linacs
DIBH [17,18], as well as a large proportion of lung cancer patients also allow automatic gated CBCT in BH. In addition to position ver-
[19] and liver cancer patients [20]. For liver and pancreatic ification and BH level verification, BH CBCT can improve imaging
tumours, a BH of 20 seconds appears to be more stable than longer quality for mobile targets considerably compared to FB CBCTs,
BH. Lens et al. described that a longer BH of 30 seconds can lead to and may help reducing interobserver registration uncertainties
a less stable tumour position, therefore shorter BHs appear to be a [1,27,28].
better approach in radiation treatments of abdominal tumours Intrafraction uncertainties such as intra- and BH-to-BH varia-
[21]. Although adequate for some treatment sites, exhale BH tions are difficult to correct and may need to be included in the
appears to be more difficult for patients, and up to 39% of patients treatment margin. Ideally, this would be done on a patient-
can be deemed unsuitable to perform an expiration BH for various specific basis: patients with small intrafractional DIBH variations
reasons [22]. benefit most from this approach, since standard margins would
result in larger margins for these patients [29]. Visual coaching
can decrease BH-to-BH variability in breast cancer patients. How-
Image-guidance for breath-hold treatments
ever, for thoracic and abdominal tumours, especially the intra-BH
variation can be difficult to assess without extensive fluoroscopic
Pre-treatment image guidance
imaging and in some cases implantation of radiopaque markers
To maximise reproducibility and reduce the risk of introducing [30–33]. Repeated DIBH CT during planning can provide an esti-
a systematic error, all relevant imaging for treatment planning mate of the BH-to-BH variation to be incorporated into individu-
should be performed in BH, and at the same BH level as used alized margins [20,34] but the method probably underestimates
throughout the treatment course. Using the same BH equipment the full extent of intrafraction motion, particularly in the abdo-
during pre-treatment imaging (dedicated CT scanners, positron men (see section 7). Therefore, cautiousness is recommended
emission tomography (PET)/CT scanners and magnetic resonance regarding PTV margins shrinkage for thoracic and abdominal
imaging (MRI) where available) and for on-treatment imaging tumours. Continuous MV or kV imaging during DIBH treatment
minimizes the risk of systematic variations between planning with open fields or with MRI on the recently clinically available
and treatment. When introducing a BH technique, some institu- MR-linacs may help us better estimate BH-to-BH and intra-BH
tions have historically acquired a FB CT followed by a BH scan dur- variations [33,35], while appropriate patient coaching may help
ing the same planning session. Although this approach can enable minimise those variations.
institutions to evaluate the dosimetric advantage of DIBH in their
own environment during the initial implementation or ‘‘learning
curve”, this approach is not recommended for routine clinical prac- Breast cancer
tice beyond the implementation stage, given the additional radia-
tion exposure. If intravenous contrast is required, it is advisable The first large-scale application of BH techniques was in
to use the contrast during the CT scan acquisition that is used for patients undergoing RT for breast cancer [36–38]. In this patient
delineating the target volume. For patients requiring PET/CT plan- group, the purpose of performing DIBH is mainly to reduce the
ning, it is possible to acquire a single PET field of view in BH (e.g. dose to the heart (by increasing the separation from the chest wall)
over 6 BHs of 20 seconds each): the PET signal acquisition can be [39], and possibly to the lungs (by increasing the total lung vol-
paused manually to allow patients to recover between BHs. In ume) [40], which can reduce the associated risks of heart disease
2015 the first use of a modified Active Breathing Coordinator [41,42] and lung cancer [43] respectively.
(ABC) in a standard MRI was described [23]. The device was mod-
ified to be MRI safe, and proof of principle of the feasibility of ABC-
Patient selection and set-up
driven DIBH during MRI was confirmed.
Several patient- and treatment-related factors may affect who is
referred to or prioritised for DIBH, such as anatomical features or
Image guidance during treatment
target volumes (e.g. regional nodal irradiation including internal
Planning target volume (PTV) margins should account for: a) mammary nodes) or laterality (left vs. right side). Patients are usu-
frequency of image guidance, b) residual tumour motion due to ally positioned supine on a flat or wedged positioning device, with
intra-BH and BH-to-BH intrafraction variation, c) differential one or both arms above the head. Reference skin marks or tattoos
motion (e.g., between involved nodes and peripheral primary can be applied in FB to facilitate initial patient alignment and set-
tumours). up, without the need of moving the patient whilst in DIBH. The
Delivery of hypofractionated treatments acquire the patient to planning CT should be performed in DIBH and additional DIBH skin
perform multiple BH with an inherent risk of exhaustion. There- marks (non-permanent) can be added as needed. An additional FB
fore, flattening filter free (FFF) beams with high output should be scan can be acquired, to create a back-up plan and/or assess the
preferred to shorten dose delivery time. effective gain between DIBH and FB plan. However, the benefits
Interfraction BH variations may be relatively large [24], and are of the acquisition of an additional FB CT scan are limited and add
not always correlated to variations in the external surrogate an increased imaging dose. The compliance in breast cancer
3
Implementation of breath-hold techniques
patients is excellent and the DIBH plan is usually not inferior to the Thoracic tumours
FB plan [49].
The primary purpose of DIBH RT for lung cancer or lymphoma is
Treatment planning and delivery: Techniques and considerations to minimise dose to the heart and lungs. For lymphoma, this is
achieved by increasing the total lung volume, as well as the separa-
DIBH is compatible with both 3D-conformal RT (3DCRT) and tion between the heart and upper-mediastinal targets. Reduced dose
Intensity Modulated Radiation Therapy (IMRT)/Volumetric Arc Ther- to the heart can decrease the risk of late radiation-induced heart dis-
apy (VMAT) techniques [44,45] and results in considerably lower ease in younger patients with a long life expectancy (e.g., those with
doses to the heart and other cardiac substructures such as the Left mediastinal Hodgkin Lymphoma) [60]. However, it is important to
Anterior Descending coronary artery (LAD). All target volumes and note that recent data suggest that heart dose also affects survival
OARs should be contoured following guidelines (i.e. ESTRO [46]). in patients with lung cancer [61,62]. More research is needed to
The maximum available dose rate should be considered to optimise understand which pathophysiological mechanisms are involved
beam delivery time (e.g. each radiation field within a single BH). and which cardiac substructures should be spared in priority.
For treatment delivery, image verification must encompass In lung cancer, an additional mode of action may be reducing
patient position (similar to treatments in FB) and verification of the motion amplitude of very mobile targets (e.g. targets close to
the BH level. As the ribs and sternum expand with the DIBH in rela- the diaphragm). However, since DIBH will introduce uncertainties
tion to the spine, the structures used for co-registration have to be both interfraction and intrafraction, it is crucial to assess the full
carefully chosen, with likely prioritisation of the upper part of the range of these uncertainties when considering any reduction of
sternum and the ribs. As with FB treatments, fiducial markers or internal target volume (ITV)/ irradiated volume [63].
surgical clips can provide additional information. Cine MV imaging
using the treatment beam can also be used to verify BH levels,
based on commercial solutions or home-made software allowing Patient selection and set-up
automatic analysis [47]; or visual evaluation [37]. SGRT and IGRT Some lung cancer patients can hold their breath long enough
are complementary technologies [48]and IGRT, specifically 3D (around 20 seconds) to facilitate treatment delivery [6,19,64] but
position verification, should be performed to get information on there are reports of insufficient respiratory capacity and poor per-
the anatomical structures. formance status in this patient population [12]. Dosimetric benefit
of DIBH for intrathoracic tumours is harder to predict than for
Published reports on uncertainties in DIBH for breast radiotherapy breast cancer patients, and, as a result, guidelines for patient selec-
tion are less straight-forward. Clinical studies have shown dosimet-
Reproducibility of the DIBH should be within 2–5 mm, regard- ric benefits with DIBH for a majority of patients (e.g. with
less of the used technique [24,49–51]. Systematic changes in BH mediastinal lymphoma [60]) but, in selected patients, DIBH can
levels may be detected during the first three treatment fractions, have a detrimental effect. If the distance between multiple targets
for example using a non-action level approach [52]. Reports of is increased in DIBH, the resulting dose delivered to the lung may
intrafraction and intra-BH reproducibility mention that an uncer- be higher than in FB [65]. Additional advantage of DIBH is improved
tainty of circa 2 mm or less is achievable [53,54]. However, there tumour visibility [28] compared to FB, especially for small mobile
may still remain a relatively large variation in heart position during tumours that would otherwise hardly be visible on 3D imaging [66].
DIBH of up to 1 cm [55]. Variations in DIBH level may be most Due to the large anatomical variation in this patient group
important in anterior-posterior (AP) direction [56,57], may occur (range of tumour size and location), it is more challenging to rec-
more frequently between fractions rather than intrafraction [24], ommend general selection criteria for DIBH. In particular, it is
and may increase with an increasing number of DIBHs per fraction important to distinguish between ‘‘simple targets” (where the
[56]. Additional verifications of BH level can include: a) the AP dis- tumour volume consists of a single solid mass), and ‘‘complex tar-
tance between the spine and sternum across the isocentre on 2D gets” with multiple target volumes (e.g. a mediastinal mass and a
set-up images, b) EPID movie loops (Figure S2), and c) 2D fluoro- peripheral lung or cardiophrenic mass).
scopic images, which are not limited to open tangential beams, With this in mind, patient selection could be based on the fol-
but cause additional dose exposure [52]. Optical surface scanners lowing criteria:
can enable a continuous real-time motion management [58] of
the patient surface during the whole fraction [48]. a) Patients with highly mobile thoracic tumours [67,68], where
In conclusion, DIBH in breast RT does not necessarily increase DIBH or other motion management approaches (abdominal
treatment precision, as new sources of uncertainties are intro- compression, expiration BH or gating) may offer margin
duced. Nevertheless, the dosimetric benefits are considerable for reduction benefits as long as DIBH-specific uncertainties
the majority of patients, especially patients with left-sided breast are also accounted for.
cancer. DIBH treatment may require an additional treatment time b) Patients with mediastinal targets where DIBH may enable
of 2–5 minutes, depending on the equipment used [59]. In the dose reduction to the heart and lungs. Note that for large
HeartSpare study, Bartlett et al. [49] found that a voluntary BH mediastinal targets extending below the heart, the dosimet-
technique (‘‘equipment free”, see S1) was associated with shorter ric benefit of DIBH may be reduced [69].
CT planning times and shorter treatment set-up times than a
spirometry-based approach (ABC, see S1). These results were Other scenarios where DIBH may be considered are dose escala-
observed despite the personnel having more experience with the tion strategies or difficulty in adhering to lung dose constraints
spirometry-based approach, and positioning reproducibility was even if the target motion is less than 5 mm (e.g. large tumours with
higher with the voluntary BH approach. little motion, where DIBH can increase the total lung volume and
Take Home message: facilitate sparing of healthy lung tissue) [70,71].
Treatment planning and delivery uncertainties, while the on-board continuous imaging can assess
residual BH-to-BH and intra-BH motion [93–95].
As mentioned above, anatomical variations in the abdomen are
Take home messages:
a combination of several physiological processes, including respi-
ration and digestion. To address this complex situation, multiple
- Anatomical variations in the abdomen occur frequently, and are
BH CT scans can be made for target delineation, and the informa-
arguably the most complex to characterise compared to other
tion used to calculate patient-specific margins [20,85]. Though
treatment sites.
these additional planning scans may provide information about
- Repeat BH CTs at the time of planning do not capture the full
residual intrafraction motion (BH-to-BH and intra-BH variation),
extent of intra-BH and BH-to-BH variations but may give infor-
the full extent of on-treatment motion may not be reflected [86].
mation about the BH-to-BH variation for the individual patient
BH fluoroscopy performed as part of the planning session can also
(to be included in the CTV-PTV margin [20].
help estimate intrafraction motion [82]. The use of population-
- Additional imaging (e.g. repeat fluoroscopy [7]) or screening
based CTV-PTV margins of 5 mm was suggested [87] but an indi-
may be required to identify patients with stable anatomy under
vidualised margin approach may be more appropriate if all
BH.
involved uncertainties can be quantified [20,27,85].
Online position verification is mandatory and registration using
bony anatomy is not recommended due to the substantial internal
Discussion
anatomical changes and deformations in this region [88,89]. Surro-
gate structures can be delineated during treatment planning in
This consensus guideline gives a broad overview of the available
order to help with image guidance, e.g., the diaphragm-liver inter-
technical solutions (see suppl. Section) and reports of their clinical
face, the liver volume, and natural, iatrogenic or implanted fidu-
implementation to date.
cials [79,88] for liver tumours. If fiducials are not present, the
In view of the available evidence, and the limited number of
diaphragm dome is often the surrogate structure of choice for liver
studies evaluating the impact of DIBH implementation and work-
tumours, but is not considered an appropriate surrogate for pan-
flow, we recommend that the ‘‘ideal” implementation would
creatic tumours [21].
include:
During treatment delivery, 2D imaging can be complemented
with fluoroscopy to assess intra-BH variations. For SBRT treat-
1) A lead professional or multi-disciplinary team to oversee the
ments a BH CBCT is recommended to assess liver deformation
process and be responsible for the implementation process,
and monitor the position of critical OARs where sparing needs to
specifically staff training and verification of the BH.
be prioritised even at the expense of PTV coverage (e.g. duodenum,
2) Adequate and appropriate time for staff training and patient
stomach and colon) [90,91].
coaching. The procedure can be streamlined later, but the
Overlaying isodoses critical for OARs onto the CBCT [82] may be
implementation requires more time.
helpful. All actions prior to treatment should be as fast as possible
3) The chosen system to be available on all scanners used for RT
to avoid patient motion (e.g a fast CBCT protocol [1]). If consider-
planning (CT, PET-CT, MRI) to ensure consistency of all
able changes in BH trace or a drift (larger than the expected BH-
images used for treatment planning, as well as (at least)
to-BH variation) are observed during treatment, imaging should
two treatment machines (linacs, ideally mirrored).
be repeated, and repositioning should be considered. If there is a
4) Daily imaging for the verification of the position of the target
systematic variation for two consecutive fractions in a SBRT treat-
in BH as well as verification of the BH level (if necessary to
ment, replanning should be considered depending on the clinical
ensure consistency in OAR sparing).
effects of this systematic variation [92], e.g. if it results in an
5) Target-related intra-fraction (intra-BH and BH-to-BH) moni-
acceptable dose to critical OARs. This needs to be decided on a
toring (rarely available at the moment)
patient-by-patient basis.
6) Ability to re-image and re-plan the patient if any change of
breathing pattern is suspected
7) Time and resources for each institution to carry its own
quality assurance programme to assess interfraction and
Published reports on uncertainties in BH for abdominal radiotherapy
(ideally) intrafraction uncertainties [96].
Compared to other tumour sites, there is a large body of
research on intrafractional uncertainties in abdominal tumours. The last point should not be underestimated: BH is a valuable
Reported intrafractional uncertainties have included BH-to-BH dis- tool, but its success may vary according to implementation proce-
placements of the tumour of > 3 mm [29], intra-BH displacements dures and patient population. As a result, each system might lead
of up to 1 cm [86]and ‘‘slow drifts” during BH [83]. Importantly, to different results in different institutions. Since ‘‘ideal” situations
these variations are not always detected by pre- and post- are rarely realistic in the real world, we would encourage users to
treatment CBCT evaluation, nor by repeated BH CTs. In contrast, consider aligning the reproducibility and accuracy of the BH proce-
in a study where patients were pre-selected before liver SBRT, dure with the complexity of their planning, delivery and image
excellent intra-BH stability (<2mm in SI direction) was observed guidance approach. The reproducibility and accuracy required
during expiration BH throughout the treatment course [7]. In this from a BH strategy will be different for a tangential breast treat-
study, patients were screened before treatment using repeat fluo- ment with open-beams (a treatment strategy more ‘‘forgiving” of
roscopies, and patients with a residual intra-BH motion uncertainties) than for a VMAT SBRT liver treatment.
of > 5 mm were deemed unsuitable for treatment in BH [7]. Ultra- In this guideline we focused on the main applications of BH and
sound imaging [31] may offer an alternative and non-ionising did not describe the use of a BH technique in children, as sparse
method of monitoring intra-BH stability. data are published concerning this population. Two studies
Motion management in the treatment of abdominal tumours, reported that the dose to the organs at risk could be diminished
especially with SBRT, is an active field of research. Recent reports using a BH technique [49,53]. The ‘‘TEDDI” trial (NCT03315546)
of MR-guided RT are offering a unique insight into geometric will investigate the dosimetric benefits as well as reproducibility
uncertainties in liver and pancreatic treatments. The online adap- and compliance/psychological impact of using breath-hold in pae-
tive pathways available on MR-linacs can address interfraction diatric patients [97].
6
M.C. Aznar, P. carrasco de fez, S. Corradini et al. Radiotherapy and Oncology 185 (2023) 109734
7
Implementation of breath-hold techniques
reduction of cardiac dose in left-sided breast irradiation for patients with [38] Sixel KE, Aznar MC, Ung YC. Deep inspiration breath hold to reduce irradiated
early-stage or locally advanced breast cancer. Am J Clin Oncol Cancer Clin heart volume in breast cancer patients. Int J Radiat Oncol Biol Phys
Trials 2013;36:24–30. https://doi.org/10.1097/COC.0b013e31823fe481. 2001;49:199–204. https://doi.org/10.1016/S0360-3016(00)01455-3.
[18] Mast M, van der Klein J, van Geen S, Jacobs M, van Wingerden J, Petoukhova A, [39] Taylor CW, Povall JM, McGale P, Nisbet A, Dodwell D, Smith JT, et al. Cardiac
et al. techniek bij vrouwen met links- zijdige borstkanker : de resultaten van Dose From Tangential Breast Cancer Radiotherapy in the Year 2006. Int J
4 jaar ervaring in Radio- therapiecentrum West. Ned Tijdschr Voor Oncol Radiat Oncol Biol Phys 2008;72:501–7. https://doi.org/10.1016/j.
2012;9:270–6. ijrobp.2007.12.058.
[19] McNair HA, Brock J, Symonds-Tayler JRN, Ashley S, Eagle S, Evans PM, et al. [40] Aznar MC, Duane FK, Darby SC, Wang Z, Taylor CW. Exposure of the lungs in
Feasibility of the use of the Active Breathing Co ordinatorTM (ABC) in patients breast cancer radiotherapy: a systematic review of lung doses published
receiving radical radiotherapy for non-small cell lung cancer (NSCLC). 2010–2015. Radiother Oncol 2018;126:148–54. https://doi.org/10.1016/j.
Radiother Oncol 2009;93:424–9. https://doi.org/10.1016/j. radonc.2017.11.022.
radonc.2009.09.012. [41] Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brnønum D,
[20] Mast M, Kouwenhoven E, Roos J, van Geen S, van Egmond J, van Santvoort J, et al. Risk of ischemic heart disease in women after radiotherapy for breast
et al. Two years’ experience with inspiration breath-hold in liver SBRT. Tech cancer. N Engl J Med 2013;368:987–98. https://doi.org/10.1056/
Innov Patient Support Radiat Oncol 2018;7:1–5. https://doi.org/10.1016/j. NEJMoa1209825.
tipsro.2018.04.001. [42] Simonetto C, Eidemüller M, Gaasch A, Pazos M, Schönecker S, Reitz D, et al.
[21] Lens E, van der Horst A, Versteijne E, Bel A, van Tienhoven G. Considerable Does deep inspiration breath-hold prolong life? Individual risk estimates of
pancreatic tumor motion during breath-holding. Acta Oncol (Madr) ischaemic heart disease after breast cancer radiotherapy. Radiother Oncol
2016;55:1360–8. https://doi.org/10.1080/0284186X.2016.1221532. 2019;131:202–7. https://doi.org/10.1016/j.radonc.2018.07.024.
[22] Dawson LA, Eccles C, Bissonnette JP, Brock KK. Accuracy of daily image [43] Taylor C, Duane FK, Dodwell D, Gray R, Wang Z, Wang Y, et al. Estimating the
guidance for hypofractionated liver radiotherapy with active breathing risks of breast cancer radiotherapy: evidence from modern radiation doses to
control. Int J Radiat Oncol Biol Phys 2005;62:1247–52. https://doi.org/ the lungs and Heart and From previous randomized trials. J Clin Oncol
10.1016/j.ijrobp.2005.03.072. 2017;35:1641–9. https://doi.org/10.1200/JCO.2016.72.0722.
[23] Kaza E, Collins DJ, Mcdonald F, Mcnair HA, Scurr E, Koh D, et al. First MRI [44] Mast ME, Van Kempen-Harteveld L, Heijenbrok MW, Kalidien Y, Rozema H,
application of an active breathing coordinator. Phys Med Biol Jansen WPA, et al. Left-sided breast cancer radiotherapy with and without
2015;60:1681–96. https://doi.org/10.1088/0031-9155/60/4/1681. breath-hold: Does IMRT reduce the cardiac dose even further? Radiother
[24] Betgen A, Alderliesten T, Sonke JJ, Van Vliet-Vroegindeweij C, Bartelink H, Oncol 2013;108:248–53. https://doi.org/10.1016/j.radonc.2013.07.017.
Remeijer P. Assessment of set-up variability during deep inspiration breath [45] Smyth LM, Knight KA, Aarons YK, Wasiak J. The cardiac dose-sparing benefits
hold radiotherapy for breast cancer patients by 3D-surface imaging. of deep inspiration breath-hold in left breast irradiation: a systematic review.
Radiother Oncol 2013;106:225–30. https://doi.org/10.1016/j. J Med Radiat Sci 2015;62:66–73. https://doi.org/10.1002/jmrs.89.
radonc.2012.12.016. [46] Offersen BV, Boersma LJ, Kirkove C, Hol S, Aznar MC, Biete Sola A, et al. ESTRO
[25] Alderliesten T, Sonke JJ, Betgen A, Honnef J, Van Vliet-Vroegindeweij C, consensus guideline on target volume delineation for elective radiation
Remeijer P. Accuracy evaluation of a 3-dimensional surface imaging system therapy of early stage breast cancer. Radiother Oncol 2015;114:3–10. https://
for guidance in deep-inspiration breath-hold radiation therapy. Int J Radiat doi.org/10.1016/j.radonc.2014.11.030.
Oncol Biol Phys 2013;85:536–42. https://doi.org/10.1016/j. [47] Poulsen PR, Thomsen MS, Hansen R, Worm E, Spejlborg H, Offersen B. Fully
ijrobp.2012.04.004. automated detection of heart irradiation in cine MV images acquired during
[26] Topolnjak R, Sonke JJ, Nijkamp J, Rasch C, Minkema D, Remeijer P, et al. Breast breast cancer radiotherapy. Radiother Oncol 2020;152:189–95. https://doi.
patient setup error assessment: Comparison of electronic portal image org/10.1016/j.radonc.2019.11.006.
devices and cone-beam computed tomography matching results. Int J Radiat [48] Freislederer P, Batista V, Öllers M, Buschmann M, Steiner E, Kügele M, et al.
Oncol Biol Phys 2010;78:1235–43. https://doi.org/10.1016/j. ESTRO-ACROP guideline on surface guided radiation therapy. Radiother Oncol
ijrobp.2009.12.021. 2022;173:188–96. https://doi.org/10.1016/j.radonc.2022.05.026.
[27] De KM, Van EJ, Kouwenhoven E, Bruijn-krist D, Ceha H, Mast M. Technical [49] Bartlett FR, Colgan RM, Carr K, Donovan EM, McNair HA, Locke I, et al. The UK
Innovations & Patient Support in Radiation Oncology Breath-hold versus mid- HeartSpare Study: randomised evaluation of voluntary deep-inspiratory
ventilation in SBRT of adrenal metastases. Tech Innov Patient Support Radiat breath-hold in women undergoing breast radiotherapy. Radiother Oncol
Oncol 2019;12:23–7. https://doi.org/10.1016/j.tipsro.2019.11.007. 2013;108:242–7. https://doi.org/10.1016/j.radonc.2013.04.021.
[28] Josipovic M, Persson GF, Bangsgaard JP, Specht L, Aznar MC. Deep inspiration [50] Kügele M, Edvardsson A, Berg L, Alkner S, Andersson Ljus C, Ceberg S.
breath-hold radiotherapy for lung cancer: Impact on image quality and Dosimetric effects of intrafractional isocenter variation during deep
registration uncertainty in cone beam CT image guidance. Br J Radiol inspiration breath-hold for breast cancer patients using surface-guided
2016;89:20160544. https://doi.org/10.1259/bjr.20160544. radiotherapy. J Appl Clin Med Phys 2018;19:25–38. https://doi.org/10.1002/
[29] Lu L, Diaconu C, Djemil T, Videtic GMM, Abdel-Wahab M, Yu N, et al. Intra- acm2.12214.
and inter-fractional liver and lung tumor motions treated with SBRT under [51] Reitz D, Walter F, Schönecker S, Freislederer P, Pazos M, Niyazi M, et al.
active breathing control. J Appl Clin Med Phys 2018;19:39–45. https://doi. Stability and reproducibility of 6013 deep inspiration breath-holds in left-
org/10.1002/acm2.12220. sided breast cancer. Radiat Oncol 2020;15:1–9. https://doi.org/10.1186/
[30] Lutz CM, Poulsen PR, Fledelius W, Offersen BV, Thomsen MS. Setup error and s13014-020-01572-w.
motion during deep inspiration breath-hold breast radiotherapy measured [52] Bortfeld T, van Herk M, Jiang SB. When should systematic patient positioning
with continuous portal imaging. Acta Oncol (Madr) 2016;55:193–200. errors in radiotherapy be corrected? Phys Med Biol 2002;47:N297–302.
https://doi.org/10.3109/0284186X.2015.1045625. https://doi.org/10.1088/0031-9155/47/23/401.
[31] Vogel L, Sihono DSK, Weiss C, Lohr F, Stieler F, Wertz H, et al. Intra-breath- [53] De Boer HCJ, Van Den Bongard DJG, Van Asselen B. Automated daily breath
hold residual motion of image-guided DIBH liver-SBRT: an estimation by hold stability measurements by real-time imaging in radiotherapy of breast
ultrasound-based monitoring correlated with diaphragm position in CBCT. cancer. Radiother Oncol 2016;119:61–4. https://doi.org/10.1016/j.
Radiother Oncol 2018;129:441–8. https://doi.org/10.1016/j. radonc.2016.02.012.
radonc.2018.07.007. [54] Xiao A, Crosby J, Malin M, Kang H, Washington M, Hasan Y, et al. Single-
[32] Scherman Rydhög J, Riisgaard de Blanck S, Josipovic M, Irming Jølck R, Larsen institution report of setup margins of voluntary deep-inspiration breath-hold
KR, Clementsen P, et al. Target position uncertainty during visually guided (DIBH) whole breast radiotherapy implemented with real-time surface
deep-inspiration breath-hold radiotherapy in locally advanced lung cancer. imaging. J Appl Clin Med Phys 2018;19:205–13. https://doi.org/10.1002/
Radiother Oncol 2017;123:78–84. https://doi.org/10.1016/j. acm2.12368.
radonc.2017.02.003. [55] van Haaren P, Claassen-Janssen F, van de Sande I, Boersma L, van der Sangen
[33] Zeng C, Xiong W, Li X, Reyngold M, Gewanter RM, Cuaron JJ, et al. M, Hurkmans C. Heart position variability during voluntary moderate deep
Intrafraction tumor motion during deep inspiration breath hold pancreatic inspiration breath-hold radiotherapy for breast cancer determined by repeat
cancer treatment. J Appl Clin Med Phys 2019;20:37–43. https://doi.org/ CBCT scans. Phys Medica 2017;40:88–94. https://doi.org/10.1016/j.
10.1002/acm2.12577. ejmp.2017.07.014.
[34] Brock KK. Imaging and image-guided radiation therapy in liver cancer. Semin [56] Kapanen M, Laaksomaa M, Pehkonen J, Haltamo M, Luukkanen H, Lehtonen T,
Radiat Oncol 2011;21:247–55. https://doi.org/10.1016/j. et al. Effects of multiple breath hold reproducibility on treatment localization
semradonc.2011.05.001. and dosimetric accuracy in radiotherapy of left-sided breast cancer with
[35] Lombardo E, Rabe M, Xiong Y, Nierer L, Cusumano D, Placidi L, et al. Offline voluntary deep inspiration breath hold technique. Med Dosim
and online LSTM networks for respiratory motion prediction in MR-guided 2017;42:177–84. https://doi.org/10.1016/j.meddos.2017.02.004.
radiotherapy. Phys Med Biol 2022:67. https://doi.org/10.1088/1361-6560/ [57] Laaksomaa M, Kapanen M, Haltamo M, Skyttä T, Peltola S, Hyödynmaa S, et al.
ac60b7. Determination of the optimal matching position for setup images and
[36] Pedersen AN, Korreman S, Nyström H, Specht L. Breathing adapted minimal setup margins in adjuvant radiotherapy of breast and lymph
radiotherapy of breast cancer: reduction of cardiac and pulmonary doses nodes treated in voluntary deep inhalation breath-hold. Radiat Oncol
using voluntary inspiration breath-hold. Radiother Oncol 2004;72:53–60. 2015;10:1–10. https://doi.org/10.1186/s13014-015-0383-y.
https://doi.org/10.1016/j.radonc.2004.03.012. [58] Reitz D, Carl G, Schönecker S, Pazos M, Freislederer P, Niyazi M, et al. Real-
[37] Korreman SS, Pedersen AN, Nøttrup TJ, Specht L, Nyström H. Breathing time intra-fraction motion management in breast cancer radiotherapy:
adapted radiotherapy for breast cancer: comparison of free breathing gating analysis of 2028 treatment sessions. Radiat Oncol 2018;13:1–9. https://doi.
with the breath-hold technique. Radiother Oncol 2005;76:311–8. https://doi. org/10.1186/s13014-018-1072-4.
org/10.1016/j.radonc.2005.07.009.
8
M.C. Aznar, P. carrasco de fez, S. Corradini et al. Radiotherapy and Oncology 185 (2023) 109734
[59] Bartlett FR, Donovan EM, McNair HA, Corsini LA, Colgan RM, Evans PM, et al. systematic review. Crit Rev Oncol Hematol 2018;129:91–101. https://doi.
The UK HeartSpare Study (Stage II): multicentre evaluation of a voluntary org/10.1016/j.critrevonc.2018.06.005.
breath-hold technique in patients receiving breast radiotherapy. Clin Oncol [81] Goodman KA. Stereotactic body radiation therapy for pancreatic cancer.
2017;29:e51–6. https://doi.org/10.1016/j.clon.2016.11.005. Cancer J (United States) 2016;22:290–5. https://doi.org/10.1097/
[60] Aznar MC, Maraldo MV, Schut DA, Lundemann M, Brodin NP, Vogelius IR, PPO.0000000000000206.
et al. Minimizing late effects for patients with mediastinal Hodgkin [82] Swaminath A, Dawson LA. Image-guided radiotherapy strategies in upper
lymphoma: deep inspiration breath-hold, IMRT, or both? Int J Radiat Oncol gastrointestinal malignancies. Front Radiat Ther Oncol 2011;43:315–30.
Biol Phys 2015;92:169–74. https://doi.org/10.1016/j.ijrobp.2015.01.013. https://doi.org/10.1159/000322470.
[61] Bradley JD, Paulus R, Komaki R, Masters G, Blumenschein G, Schild S, et al. [83] Lens E, Gurney-Champion OJ, Tekelenburg DR, van Kesteren Z, Parkes MJ, van
Standard-dose versus high-dose conformal radiotherapy with concurrent and Tienhoven G, et al. Abdominal organ motion during inhalation and exhalation
consolidation carboplatin plus paclitaxel with or without cetuximab for breath-holds: pancreatic motion at different lung volumes compared.
patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a Radiother Oncol 2016;121:268–75. https://doi.org/10.1016/j.
randomised, two-by-two factorial p. Lancet Oncol 2015;16:187–99. https:// radonc.2016.09.012.
doi.org/10.1016/S1470-2045(14)71207-0. [84] Huang TJ, Huang TJ, Tien Y, Tien Y, Wu JK, Huang WT, et al. Impact of breath-
[62] Atkins KM, Rawal B, Chaunzwa TL, Lamba N, Bitterman DS, Williams CL, et al. hold level on positional error aligned by stent/Lipiodol in Hepatobiliary
Cardiac radiation dose, cardiac disease, and mortality in patients with lung radiotherapy with breath-hold respiratory control. BMC Cancer 2020;20:1–9.
cancer. J Am Coll Cardiol 2019;73:2976–87. https://doi.org/10.1016/ https://doi.org/10.1186/s12885-020-07082-y.
j.jacc.2019.03.500. [85] Van Der Pool AEM, Méndez Romero A, Wunderink W, Heijmen BJ, Levendag
[63] Ottosson W, Rand Momsen NC, Fortin Jørgensen S, Bekke SN, Sibolt P, Behrens PC, Verhoef C, et al. Stereotactic body radiation therapy for colorectal liver
CP, et al. PD-0232 Large intra-fractional tumor position variations in deep- metastases. Br J Surg 2010;97:377–82. https://doi.org/10.1002/bjs.6895.
inspiration breath-hold lung SBRT. Radiother Oncol 2022;170:S192–3. [86] Stick LB, Vogelius IR, Risum S, Josipovic M. Intrafractional fiducial marker
https://doi.org/10.1016/s0167-8140(22)02787-6. position variations in stereotactic liver radiotherapy during voluntary deep
[64] Mah D, Hanley J, Rosenzweig KE, Yorke E, Braban L, Ling CC, et al. Technical inspiration breath-hold. Br J Radiol 2020;93:1–7. https://doi.org/10.1259/
aspects of the deep inspiration breath-hold technique in the treatment of bjr.20200859.
thoracic cancer. Int J Radiat Oncol Biol Phys 2000;48:1175–85. https://doi. [87] Hawkins MA, Brock KK, Eccles C, Moseley D, Jaffray D, Dawson L. Assessment
org/10.1016/S0360-3016(00)00747-1. of residual error in liver position using kV cone-beam computed tomography
[65] Josipovic M, Aznar MC, Persson GF. Deep inspiration breath hold radiotherapy for liver cancer high-precision therapy. Int J Radiat Oncol Biol Phys
of lung cancer: the good, the bad and the ugly case. Acta Oncol (Madr) 2006;66:610–9. https://doi.org/10.1016/j.ijrobp.2006.03.026.
2014;53:1446–8. https://doi.org/10.3109/0284186X.2014.922216. [88] Seppenwoolde Y, Wunderink W, Van VS, Storchi P, Romero AM, Heijmen BJM.
[66] Aznar MC, Warren S, Hoogeman M, Josipovic M. The impact of technology on Treatment precision of image-guided liver SBRT using implanted fiducial
the changing practice of lung SBRT. Phys Medica 2018;47:129–38. https:// markers depends on marker-tumour distance. Phys Med Biol
doi.org/10.1016/j.ejmp.2017.12.020. 2011;56:5445–68. https://doi.org/10.1088/0031-9155/56/17/001.
[67] Keall PJ, Mageras GS, Balter JM, Emery RS, Forster KM, Jiang SB, et al. The [89] Wunderink W, Méndez Romero A, Seppenwoolde Y, De Boer H, Levendag P,
management of respiratory motion in radiation oncology report of AAPM Heijmen B. Potentials and limitations of guiding liver stereotactic body
Task Group 76. Med Phys 2006;33:3874–900. https://doi.org/10.1118/ radiation therapy set-up on liver-implanted fiducial markers. Int J Radiat
1.2349696. Oncol Biol Phys 2010;77:1573–83. https://doi.org/10.1016/j.
[68] Ottosson W, Rahma F, Sjöström D, Behrens CF, Sibolt P. The advantage of ijrobp.2009.10.040.
deep-inspiration breath-hold and cone-beam CT based soft-tissue [90] Méndez Romero A, Zinkstok RT, Wunderink W, van Os RM, Joosten H,
registration for locally advanced lung cancer radiotherapyDIBH Seppenwoolde Y, et al. Stereotactic body radiation therapy for liver tumors:
radiotherapy for lung cancer patients. Radiother Oncol 2016;119:432–7. impact of daily setup corrections and day-to-day anatomic variations on dose
https://doi.org/10.1016/j.radonc.2016.03.012. in target and organs at risk. Int J Radiat Oncol Biol Phys 2009;75:1201–8.
[69] Everett AS, Hoppe BS, Louis D, McDonald AM, Morris CG, Mendenhall NP, https://doi.org/10.1016/j.ijrobp.2008.12.020.
et al. Comparison of techniques for involved-site radiation therapy in patients [91] Scorsetti M, Arcangeli S, Tozzi A, Comito T, Alongi F, Navarria P, et al. Is
with lower mediastinal lymphoma. Pract Radiat Oncol 2019;9:426–34. stereotactic body radiation therapy an attractive option for unresectable liver
https://doi.org/10.1016/j.prro.2019.05.009. metastases? A preliminary report from a phase 2 trial. Int J Radiat Oncol Biol
[70] Partridge M, Tree A, Brock J, McNair H, Fernandez E, Panakis N, et al. Phys 2013;86:336–42. https://doi.org/10.1016/j.ijrobp.2012.12.021.
Improvement in tumour control probability with active breathing control and [92] Leinders SM, Breedveld S, Méndez Romero A, Schaart D, Seppenwoolde Y,
dose escalation: a modelling study. Radiother Oncol 2009;91:325–9. https:// Heijmen BJM. Adaptive liver stereotactic body radiation therapy: automated
doi.org/10.1016/j.radonc.2009.03.017. daily plan reoptimization prevents dose delivery degradation caused by
[71] Persson GF, Scherman Rydhög J, Josipovic M, Maraldo MV, Nygård L, Costa J, anatomy deformations. Int J Radiat Oncol Biol Phys 2013;87:1016–21.
et al. Deep inspiration breath-hold volumetric modulated arc radiotherapy https://doi.org/10.1016/j.ijrobp.2013.08.009.
decreases dose to mediastinal structures in locally advanced lung cancer. [93] van Sörnsen de Koste JR, Palacios MA, Bruynzeel AME, Slotman BJ, Senan S,
Acta Oncol (Madr) 2016;55:1053–6. https://doi.org/10.3109/ Lagerwaard FJ. MR-guided gated stereotactic radiation therapy delivery for
0284186X.2016.1142115. lung, adrenal, and pancreatic tumors: a geometric analysis. Int J Radiat Oncol
[72] Feng M, Moran JM, Koelling T, Chughtai A, Chan JL, Freedman L, et al. Biol Phys 2018;102:858–66. https://doi.org/10.1016/j.ijrobp.2018.05.048.
Development and validation of a heart atlas to study cardiac exposure to [94] Bohoudi O, Bruynzeel AME, Senan S, Cuijpers JP, Slotman BJ, Lagerwaard FJ,
radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys et al. Fast and robust online adaptive planning in stereotactic MR-guided
2011;79:10–8. https://doi.org/10.1016/j.ijrobp.2009.10.058. adaptive radiation therapy (SMART) for pancreatic cancer. Radiother Oncol
[73] Duane F, Aznar MC, Bartlett F, Cutter DJ, Darby SC, Jagsi R, et al. A cardiac 2017;125:439–44. https://doi.org/10.1016/j.radonc.2017.07.028.
contouring atlas for radiotherapy. Radiother Oncol 2017;122:416–22. https:// [95] Boldrini L, Corradini S, Gani C, Henke L, Hosni A, Romano A, et al. MR-Guided
doi.org/10.1016/j.radonc.2017.01.008. Radiotherapy for Liver Malignancies. Front Oncol 2021;11:1–13. https://doi.
[74] Brock J, McNair HA, Panakis N, Symonds-Tayler R, Evans PM, Brada M. The use org/10.3389/fonc.2021.616027.
of the active breathing coordinator throughout radical non-small-cell lung [96] Remonnay R, Morelle M, Giraud P, Carrère MO. The cost of respiration-gated
cancer (NSCLC) radiotherapy. Int J Radiat Oncol Biol Phys 2011;81:369–75. radiotherapy in the framework of a clinical research programme ‘‘STIC”.
https://doi.org/10.1016/j.ijrobp.2010.05.038. Cancer/Radiotherapie 2009;13:281–90. https://doi.org/10.1016/
[75] Peng Y, Vedam S, Chang JY, Gao S, Sadagopan R, Bues M, et al. Implementation j.canrad.2009.03.001.
of feedback-guided voluntary breath-hold gating for cone beam CT-based [97] Lundgaard AY, Hjalgrim LL, Rechner LA, Josipovic M, Joergensen M, Aznar MC,
stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2011;80:909–17. et al. TEDDI: Radiotherapy delivery in deep inspiration for pediatric patients -
https://doi.org/10.1016/j.ijrobp.2010.08.011. A NOPHO feasibility study. Radiat Oncol 2018;13:11–3. https://doi.org/
[76] Møller DS, Schmidt ML, Ravkilde T, Poulsen PR, Hansen J, Worm ES, et al. PO- 10.1186/s13014-018-1003-4.
0974 Intra-fractional stability of Deep Inspiration Breath Hold during RT for [98] Parkes MJ, Green S, Stevens AM, Parveen S, Stephens R, Clutton-Brock TH.
lung and lymphoma cancer. Radiother Oncol 2019;133:S531–2. https://doi. Safely prolonging single breath-holds to >5min in patients with cancer;
org/10.1016/s0167-8140(19)31394-5. feasibility and applications for radiotherapy. Br J Radiol 2016;89:20160194.
[77] Langen KM, Jones DTL. Organ motion and its management. Int J Radiat Oncol https://doi.org/10.1259/bjr.20160194.
Biol Phys 2001;50:265–78. https://doi.org/10.1016/S0360-3016(01)01453-5. [99] Corradini S, Alongi F, Andratschke N, Belka C, Boldrini L, Cellini F, et al. MR-
[78] Abbas H, Chang B, Chen Z. Motion management in gastrointestinal cancers. J guidance in clinical reality: current treatment challenges and future
Gastrointest Oncol 2014;5:223–35. https://doi.org/10.3978/j.issn.2078- perspectives. Radiat Oncol 2019;14:1–12. https://doi.org/10.1186/s13014-
6891.2014.028. 019-1308-y.
[79] Brock KK, Dawson LA. Adaptive management of liver cancer radiotherapy. [100] Massaccesi M, Cusumano D, Boldrini L, Dinapoli N, Fionda B, Teodoli S, et al. A
Semin Radiat Oncol 2010;20:107–15. https://doi.org/10.1016/j. new frontier of image guidance: Organs at risk avoidance with MRI-guided
semradonc.2009.11.004. respiratory-gated intensity modulated radiotherapy: technical note and
[80] Kobiela J, Spychalski P, Marvaso G, Ciardo D, Dell’Acqua V, Kraja F, et al. report of a case. J Appl Clin Med Phys 2019;20:194–8. https://doi.org/
Ablative stereotactic radiotherapy for oligometastatic colorectal cancer: 10.1002/acm2.12575.